5 Pharma Trends for 2023: Challenges and opportunities in the post-COVID landscape
Pharma is facing a new set of launch, market access and strategic challenges as the pandemic has changed some market characteristics for good.
Our products
Pharma is facing a new set of launch, market access and strategic challenges as the pandemic has changed some market characteristics for good.
From pricing concerns, reputational damage control, Trumpian uncertainty, technology convergence to multichannel, we predict the key pharma trends for 2017.
Pharmaceutical companies must ensure that each component of their product launch plan makes a meaningful contribution to return on investment (ROI).
By optimising the efficiency and impact of a launch programme, you can maintain ROI from new products at realistic levels that will keep R&D ticking over and continue providing incentives for pharma companies and their investors to pursue better health outcomes.
Medicines need to make a profit. Making launches count: pharma and biotech ROI under strain
We predict the top pharma trends for 2016 including creative new approaches to drug pricing and reimbursement and building a digital-health ecosystem.
Market access is all about fine-tuning global plans to local demands. How do you stay on top of launch risks as your new product rolls out internationally?
Launch risks are a fact of life when new drugs come to market. How do you ensure those risks stay visible and manageable across your organisation?
With marginal returns on new product launches, a revolution in the digital tools that support pharma launch readiness has taken place.
From technology to transparency, collaboration to acquisitions, we predict the key pharma trends of 2015 that will affect the industry.
Your global launch team is one of your best assets, but are they wasting time with too many admin tasks? Find out how to make your talent shine.
Collaboration is a key pillar of a successful pharma launch - watch out for these 5 signs that your launch team is not collaborating effectively.
Global value dossiers are the key to getting your products to market but when they’re done badly, they waste valuable time and resource.
TRiBECA Knowledge needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For more information on how to unsubscribe, our privacy practices, and how we are committed to protecting and respecting your privacy, please review our Privacy Notice.